PROCEPT BioRobotics

PROCEPT BioRobotics

Develops robotic solutions for BPH treatment

About

PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, and the company generates revenue through the sale of the AquaBeam system and its disposable components, as well as offering training and support services. PROCEPT BioRobotics stands out from competitors by providing a solution that ensures predictable outcomes and minimizes complications, ultimately enhancing patient quality of life. The goal of the company is to improve surgical procedures and patient outcomes in the treatment of BPH.

Company Stage

IPO

Employees

501-1,000

Industries

Biotechnology, Healthcare

Total Funding

$637.7M

Headquarters

N/A

Founded

2009


Simplify Jobs

Simplify's Take

What believers are saying

  • Long-term data demonstrating the sustained benefits of Aquablation therapy enhances the company's reputation and supports its market position.
  • Significant investments, including $118 million in equity financing, provide the financial resources needed for global expansion and innovation.
  • FDA approval for investigating Aquablation therapy for prostate cancer opens new market opportunities and potential revenue streams.

What critics are saying

  • Ongoing investigations by law firms into possible securities fraud could damage the company's reputation and investor confidence.
  • The medical device market is highly competitive, and maintaining technological leadership requires continuous innovation and substantial investment.

What makes PROCEPT BioRobotics unique

  • PROCEPT BioRobotics specializes in Aquablation therapy, a unique minimally invasive treatment for BPH that combines real-time imaging, robotics, and waterjet technology, setting it apart from traditional surgical methods.
  • The company's focus on urology and the treatment of BPH allows it to develop highly specialized and effective solutions, unlike competitors with broader medical device portfolios.
  • The inclusion of PROCEPT's technology in clinical practice guidelines underscores its credibility and effectiveness, distinguishing it from less established competitors.

Help us improve and share your feedback! Did you find this helpful?


Growth & Insights
Headcount

6 month growth

11%

1 year growth

33%

2 year growth

113%

Recently Posted Jobs

Sign up to get curated job recommendations

PROCEPT BioRobotics is Hiring for 0 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update PROCEPT BioRobotics's jobs every 8 hours, so check again soon! Browse all jobs →